These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9266584)
1. Antiretroviral therapy during pregnancy. Beyond AZT (ZDV). Dattel BJ Obstet Gynecol Clin North Am; 1997 Sep; 24(3):645-57. PubMed ID: 9266584 [TBL] [Abstract][Full Text] [Related]
2. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044 [TBL] [Abstract][Full Text] [Related]
3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Siegfried N; van der Merwe L; Brocklehurst P; Sint TT Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394 [TBL] [Abstract][Full Text] [Related]
4. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Mofenson LM; MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844 [TBL] [Abstract][Full Text] [Related]
5. Prevention of mother-to-child HIV transmission using 3-drug combination antiretroviral treatment: observational cohort in clinical practice setting in India. Patel AK; Patel KK; Sharma R; Ranjan RR; Shukla RK; Patel JA J Acquir Immune Defic Syndr; 2009 Feb; 50(2):231-3. PubMed ID: 19155769 [No Abstract] [Full Text] [Related]
6. Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission. Giaquinto C; De Romeo A; Giacomet V; Rampon O; Ruga E; Burlina A; De Rossi A; Sturkenboom M; D'Elia R AIDS; 2001 May; 15(8):1074-5. PubMed ID: 11399997 [No Abstract] [Full Text] [Related]
7. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL; J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045 [TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy in pregnancy: a focus on safety. Taylor GP; Low-Beer N Drug Saf; 2001; 24(9):683-702. PubMed ID: 11522121 [TBL] [Abstract][Full Text] [Related]
9. Long-term antiretroviral combination therapy including lamivudine in HIV-1 infected women during pregnancy. Grubert TA; Wintergerst U; Lutz-Friedrich R; Belohradsky BH; Rolinski B AIDS; 1999 Jul; 13(11):1430-1. PubMed ID: 10449309 [No Abstract] [Full Text] [Related]
10. Antiretroviral therapy in the pregnant woman. Augenbraun M; Minkoff HL Obstet Gynecol Clin North Am; 1997 Dec; 24(4):833-54. PubMed ID: 9430170 [TBL] [Abstract][Full Text] [Related]
11. Management of human immunodeficiency virus infection in pregnancy. Watts DH N Engl J Med; 2002 Jun; 346(24):1879-91. PubMed ID: 12063373 [No Abstract] [Full Text] [Related]
12. Antiretroviral treatments to reduce mother-to-child transmission of HIV. Peiperl L HIV Clin Trials; 2001; 2(1):46-55. PubMed ID: 11590514 [No Abstract] [Full Text] [Related]
13. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era? Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S; Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147 [TBL] [Abstract][Full Text] [Related]
14. Trends in antiretroviral therapy and mother-infant transmission of HIV. The Women and Infants Transmission Study Group. Cooper ER; Charurat M; Burns DN; Blattner W; Hoff R J Acquir Immune Defic Syndr; 2000 May; 24(1):45-7. PubMed ID: 10877494 [TBL] [Abstract][Full Text] [Related]
15. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy. Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009 [TBL] [Abstract][Full Text] [Related]
16. Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV? Nightingale S; Dabis F J Trop Pediatr; 2006 Aug; 52(4):235-8. PubMed ID: 16877674 [No Abstract] [Full Text] [Related]
18. Trial in youngest group points to HIV treatment overhaul. Dolgin E Nat Med; 2011 Apr; 17(4):393. PubMed ID: 21475208 [No Abstract] [Full Text] [Related]
19. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy. Senise JF; Castelo A; MartĂnez M AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356 [TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy in HIV-infected pregnant women and their infants: current interventions and challenges. Shannon M J Perinat Neonatal Nurs; 2002 Sep; 16(2):1-25. PubMed ID: 12233942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]